Katherine Stueland - 29 Apr 2023 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
Chief Executive Officer
Signature
/s/ Eunkyung Lee, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
29 Apr 2023
Net transactions value
$0
Form type
4
Filing time
02 May 2023, 20:34:31 UTC
Previous filing
27 Apr 2023
Next filing
18 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise $0 -511,364 -38% $0.000000 819,938 29 Apr 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Restricted Stock Unit Options Exercise $0 -511,364 -25% $0.000000 1,534,090 29 Apr 2023 Class A Common Stock 511,364 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2 25% of the total shares underlying the restricted stock units vest on each of April 29, 2023 and April 29, 2024, and thereafter 6.25% of the total shares underlying the restricted stock units shall vest in equal quarterly installments until fully vested on April 29, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Remarks:

For avoidance of doubt, all numbers presented above reflect shares issued before giving effect to the 33:1 reverse stock split the Issuer's stockholders approved on April 14, 2023, which was previously announced in the Current Report on Form 8-K filed by the Issuer on April 17, 2023, and which shall become effective on May 4, 2023.